Bone turnover biomarkers identify unique prognostic risk groups in men with castration resistant prostate cancer and skeletal metastases: results from SWOG S0421

BACKGROUND. Skeletal metastases often occur in men with castration-resistant prostate cancer (CRPC) where bone biomarkers are prognostic for overall survival (OS). In those with highly elevated markers, there is preferential benefit from bone-targeted therapy. In the phase IIIS0421 docetaxel+/− atra...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Treat Res Commun
Huvudupphovsmän: Lara, PN, Plets, M, Tangen, C, Gertz, E, Vogelzang, NJ, Hussain, M, Twardowski, PW, Garzotto, MG, Monk, JP, Carducci, M, Goldkorn, A, Mack, PC, Thompson, I, Van Loan, M, Quinn, DI
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2018
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6628720/
https://ncbi.nlm.nih.gov/pubmed/31298998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctarc.2018.04.005
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk